Macquarie Group’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-333
| Closed | -$4.83K | – | 1721 |
|
|
2025
Q1 | $4.83K | Buy |
+333
| New | +$4.73K | ﹤0.01% | 1679 |
|
|
2022
Q4 | – | Sell |
-2,084
| Closed | -$39K | – | 1971 |
|
|
2022
Q3 | $39K | Sell |
2,084
-273
| -12% | -$5.5K | ﹤0.01% | 2018 |
|
|
2022
Q2 | $50K | Hold |
2,357
| – | – | ﹤0.01% | 2055 |
|
|
2022
Q1 | $55 | Hold |
2,357
| – | – | ﹤0.01% | 2110 |
|
|
2021
Q4 | $64K | Sell |
2,357
-804
| -25% | -$21.5K | ﹤0.01% | 2079 |
|
|
2021
Q3 | $90K | Hold |
3,161
| – | – | ﹤0.01% | 2019 |
|
|
2021
Q2 | $95K | Sell |
3,161
-32,990
| -91% | -$974K | ﹤0.01% | 1984 |
|
|
2021
Q1 | $921K | Sell |
36,151
-933
| -3% | -$23.9K | ﹤0.01% | 1414 |
|
|
2020
Q4 | $910K | Hold |
37,084
| – | – | ﹤0.01% | 1336 |
|
|
2020
Q3 | $604K | Hold |
37,084
| – | – | ﹤0.01% | 1358 |
|
|
2020
Q2 | $634K | Buy |
37,084
+2,084
| +6% | +$30.9K | ﹤0.01% | 1302 |
|
|
2020
Q1 | $408K | Hold |
35,000
| – | – | ﹤0.01% | 1317 |
|
|
2019
Q4 | $973K | Buy |
35,000
+8,400
| +32% | +$211K | ﹤0.01% | 1259 |
|
|
2019
Q3 | $602K | Buy |
+26,600
| New | +$606K | ﹤0.01% | 1337 |
|
|
2018
Q1 | – | Sell |
-4,900
| Closed | -$262K | – | 2287 |
|
|
2017
Q4 | $262K | Buy |
4,900
+1,300
| +36% | +$61.3K | ﹤0.01% | 1660 |
|
|
2017
Q3 | $155K | Sell |
3,600
-60,650
| -94% | -$2.88M | ﹤0.01% | 1823 |
|
|
2017
Q2 | $3.88M | Buy |
64,250
+50
| +0.1% | +$2.96K | 0.01% | 808 |
|
|
2017
Q1 | $4.45M | Sell |
64,200
-250
| -0.4% | -$17.4K | 0.01% | 772 |
|
|
2016
Q4 | $4.3M | Sell |
64,450
-100
| -0.2% | -$6.5K | 0.01% | 765 |
|
|
2016
Q3 | $4.28M | Sell |
64,550
-55,850
| -46% | -$3.82M | 0.01% | 769 |
|
|
2016
Q2 | $8.72M | Buy |
120,400
+13,375
| +12% | +$919K | 0.01% | 744 |
|
|
2016
Q1 | $6.92M | Buy |
107,025
+46,775
| +78% | +$3.1M | 0.01% | 639 |
|
|
2015
Q4 | $4.32M | Sell |
60,250
-59,000
| -49% | -$4.36M | 0.01% | 738 |
|
|
2015
Q3 | $9.16M | Buy |
119,250
+50
| +0% | +$4.04K | 0.02% | 562 |
|
|
2015
Q2 | $8.83M | Buy |
119,200
+68,400
| +135% | +$4.92M | 0.02% | 587 |
|
|
2015
Q1 | $3.68M | Hold |
50,800
| – | – | 0.01% | 841 |
|
|
2014
Q4 | $3.36M | Hold |
50,800
| – | – | 0.01% | 856 |
|
|
2014
Q3 | $2.79M | Hold |
50,800
| – | – | 0.01% | 898 |
|
|
2014
Q2 | $2.95M | Hold |
50,800
| – | – | 0.01% | 898 |
|
|
2014
Q1 | $3.15M | Sell |
50,800
-15,249
| -23% | -$887K | 0.01% | 848 |
|
|
2013
Q4 | $3.53M | Sell |
66,049
-30,551
| -32% | -$1.64M | 0.01% | 734 |
|
|
2013
Q3 | $4.85M | Hold |
96,600
| – | – | 0.01% | 622 |
|
|
2013
Q2 | $4.42M | Buy |
+96,600
| New | +$4.32M | 0.01% | 629 |
|
Other funds holding MD
Macquarie Group's MD Position: Q2 2025 in Review
Macquarie Group sold out of Pediatrix Medical (MD) in Q2 2025, closing a stake of 333 shares — an estimated $4.83K sold.
Macquarie Group first reported a position in MD in Q2 2013 and held it in 33 quarters. The position peaked at $9.16M in Q3 2015. 264 funds tracked by Wall St. Rank hold MD as of Q2 2025.
- Macquarie Group reported no remaining Pediatrix Medical position as of Q2 2025 after selling out during the quarter.
- Macquarie Group sold 333 Pediatrix Medical shares in Q2 2025, an estimated $4.83K.
- Macquarie Group first reported a position in Pediatrix Medical in Q2 2013 and held it in 33 quarters.
- Macquarie Group's Pediatrix Medical position peaked at $9.16M in Q3 2015.
- 264 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2025.
Based on Macquarie Group's 13F filing for Q2 2025, filed 14 Aug 2025.